Article
Left atrial shortening fraction in fetuses with and without myocardial hypertrophy in diabetic pregnancies
Registro en:
ZIELINSKY, P. et al. Left atrial shortening fraction in fetuses with and without myocardial hypertrophy in diabetic pregnancies. Ultrasound obstet. gynecol., Carnforth, v. 33, p. 182–187, 2009.
10.1002/uog.6154
Autor
Zielinsky, P.
Luchese, S.
Manica, J. L.
Piccoli Junior, A. L.
Nicoloso, L. H.
Leite, M. F.
Hagemann, L.
Busato, A.
Moraes, M. R.
Resumen
ObjectiveTo test the hypothesis that, in diabetic
pregnancies, left atrial shortening fraction (LASF) is
decreased in fetuses with myocardial hypertrophy,
compared to those without hypertrophy and to fetuses
of non-diabetic mothers.
MethodsFetal echocardiography was performed in
women with pre-existing or gestational diabetes and in
non-diabetic controls between 25 weeks’ gestation and
term. LASF was calculated using the formula: (end-systolic diameter – end-diastolic diameter)/end-systolic
diameter, and data were compared between diabetic
women with and without fetal myocardial hypertrophy
and controls.
ResultsThe study population comprised 53 diabetic
women and 45 controls. Out of the 53 fetuses of diabetic
women, 14 had myocardial hypertrophy and 39 had
normal septal thickness. Gestational age at the time
of examination did not differ significantly between the
control group and the two diabetic subgroups (P=0.57).
Fetuses with myocardial hypertrophy presented a mean
(±SD)LASFof0.32±0.11, those without myocardial
hypertrophy 0.46±0.12, and those of normal mothers
0.53±0.09 (P<0.001). A significant inverse linear
correlation was observed between LASF and septal
thickness (r=−0.51,P<0.001).
ConclusionsIn diabetic pregnancies, LASF is lower in
fetuses with myocardial hypertrophy than it is in those
without hypertrophy and in fetuses of non-diabetic
women, suggesting that LASF could be a useful alternative
parameter in the assessment of fetal diastolic function.